RXMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RXMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Progressive Care's share price is $2.11. Progressive Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $8.82. Hence, Progressive Care's PS Ratio for today is 0.24.
The historical rank and industry rank for Progressive Care's PS Ratio or its related term are showing as below:
During the past 13 years, Progressive Care's highest PS Ratio was 3.87. The lowest was 0.01. And the median was 0.45.
Progressive Care's Revenue per Sharefor the three months ended in Jun. 2024 was $2.16. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $8.82.
Warning Sign:
Progressive Care Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Progressive Care was -30.50% per year.
During the past 13 years, Progressive Care's highest 3-Year average Revenue per Share Growth Rate was 100.30% per year. The lowest was -46.80% per year. And the median was 2.85% per year.
The historical data trend for Progressive Care's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progressive Care Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
PS Ratio | Get a 7-Day Free Trial | 0.69 | 0.40 | 0.45 | 0.47 | - |
Progressive Care Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
PS Ratio | Get a 7-Day Free Trial | 0.35 | 0.36 | - | 0.25 | 0.18 |
For the Pharmaceutical Retailers subindustry, Progressive Care's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's PS Ratio distribution charts can be found below:
* The bar in red indicates where Progressive Care's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Progressive Care's PS Ratio for today is calculated as
PS Ratio | = | Share Price | / | Revenue per Share (TTM) |
= | 2.11 | / | 8.824 | |
= | 0.24 |
Progressive Care's Share Price of today is $2.11.
Progressive Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.82.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PS Ratio | = | Market Cap | / | Revenue |
The Revenue here is for the trailing 12 months.
Progressive Care (OTCPK:RXMD) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.
Be Aware
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Thank you for viewing the detailed overview of Progressive Care's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles M. Fernandez | director, 10 percent owner, officer: Chairman & CEO | C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137 |
Rodney Barreto | director, 10 percent owner | 460 MARQUESA DRIVE, CORAL GABLES FL 33156 |
Pamela M Roberts | officer: CHIEF OPERATING OFFICER | 1540 NW 203 ST, MIAMI FL 33169 |
Pedro Rodriguez | director | 258 NE 27TH STREET, MIAMI FL 33137 |
Birute Norkute | officer: Chief Operating Officer | 2311 NE 174TH ST, MIAMI FL 33160 |
Alan Jay Weisberg | officer: CHIEF FINANCIAL OFFICER | 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431 |
Cecile Munnik | officer: CFO | 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009 |
Joseph Ziegler | director | 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062 |
Jervis Hough | director | 6053 BARTAM COVE, DULUTH GA 30097 |
Shital P Parikh | director, officer: Chief Operating Officer | 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169 |
Vernon Watson | officer: Chief Executive Officer | 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169 |
Armen Karapetyan | 10 percent owner | 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160 |
Avraham A. Friedman | director, 10 percent owner, officer: Chief Executive Officer | C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162 |
Andy Subachan | director, 10 percent owner, officer: Chief Operating Officer | C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162 |
Buddy Young | director, 10 percent owner, officer: President, CEO, CFO, Chairman |
From GuruFocus
By PRNewswire • 05-15-2024
By Value_Insider Value_Insider • 11-15-2022
By Value_Insider Value_Insider • 11-15-2022
By PRNewswire • 11-20-2023
By PurpleRose PurpleRose • 08-12-2022
By GlobeNewswire GlobeNewswire • 05-11-2023
By PRNewswire • 08-14-2024
By GuruFocus Research • 02-14-2024
By sperokesalga sperokesalga • 05-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.